Even after completing therapy, breast cancer survivors often face a heightened risk of gum inflammation and periodontal diseases. This increased susceptibility arises from medications that can alter ...

Olympus Corporation (Olympus), a global MedTech company committed to making people’s lives healthier, safer and more ...

Olympus Corporation (Olympus), a global MedTech company committed to making people's lives healthier, safer and more fulfilling, today announced the launch of the NBI+TXI(TM) observation mode, which ...

Icotrokinra demonstrated clinically meaningful outcomes at Week 28 in the Phase 2b ANTHEM-UC study in ulcerative colitis, with 31.7% of patients achieving clinical remission and 38.1% showing ...

BEVs carry diverse molecular cargo that offers non-invasive biomarkers for early diagnosis and monitoring of PCOS and ...

Scientists have demonstrated for the first time how Staphylococcus aureus—a leading cause of skin infections—reshapes the ...

Mucoceles are benign sinus tumors that are caused by an obstruction in the sinus ostium. We report 3cases managed at the University Hospital of Kamenge, where treatment was surgical via an endoscopic ...

The McGill IBD Research Group, in partnership with the Montreal General Hospital Foundation, will hold its annual fundraising ...

Anogenital lichen planus (ALP) is a chronic inflammatory condition associated with significant morbidity, persistent symptoms ...

Merck and Eisai Provide Update on Phase 3 LEAP-012 Trial in Unresectable, Non-Metastatic Hepatocellular Carcinoma ...